Pyxis Oncology, Inc. (PYXS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Pyxis Oncology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.90x | -1.18x | -0.97x | -0.37x | -4.65x | -35.30x |
| P/B Ratio | 1.34x | 0.76x | 0.57x | 0.28x | 1.35x | -28.95x |
| P/S Ratio | 5.16x | 5.65x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 82.8% | 97.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -609.2% | -554.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -574.5% | -478.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -576.6% | -405.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.41x | 7.49x | 4.84x | 5.90x | 14.90x | 2.20x |
| Quick Ratio | 3.41x | 7.49x | 4.84x | 5.90x | 14.90x | 2.20x |
| Leverage | ||||||
| Debt/Equity | 0.35x | 0.17x | 0.17x | 0.12x | 0.00x | -0.05x |
YoY = year-over-year change. Source: FMP..